Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

In 2021, 47,412 HCT (19,806 (42%) allogeneic and 27,606 (58%) autologous) in 43,109 patients were reported by 694 European centers. 3494 patients received advanced cellular therapies, 2524 of which were CAR-T treatments, an additional 3245 received DLI. Changes compared to the previous year were CAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Passweg, Jakob R., Baldomero, Helen, Ciceri, Fabio, Corbacioglu, Selim, de la Cámara, Rafael, Dolstra, Harry, Glass, Bertram, Greco, Raffaella, McLornan, Donal P., Neven, Bénédicte, de Latour, Régis Peffault, Perić, Zinaida, Ruggeri, Annalisa, Snowden, John A., Sureda, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987384/
https://www.ncbi.nlm.nih.gov/pubmed/36879108
http://dx.doi.org/10.1038/s41409-023-01943-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987384/
https://www.ncbi.nlm.nih.gov/pubmed/36879108
http://dx.doi.org/10.1038/s41409-023-01943-3

Ejemplares similares